» Articles » PMID: 34812235

Clinical Experience of Transcatheter Closure for Ventricular Septal Defects in Children Weighing Under 15 Kg

Overview
Date 2021 Nov 23
PMID 34812235
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Failure to thrive and poor weight gain are the main problems associated with ventricular septal defects complicated by heart failure in pediatric patients. Recent advances in transcatheter closure have enabled safe and effective interventions in these patients.

Objectives: The purpose of this study was to describe our experience with transcatheter closure of ventricular septal defects in young children with low weight.

Methods: Pediatric patients weighing < 15 kg who underwent transcatheter closure of ventricular septal defects between January 2018 and December 2019 at our hospital were retrospectively enrolled.

Results: Twelve patients were enrolled: one with a muscular defect, two with outlet defects, and nine with perimembranous defects. Their median age was 24 (7-60) months, and their median weight before the procedure was 11.8 kg (4.7-14.9 kg; mean Z-score: -1.3). The median precordial echocardiographic defect diameter was 5.6 (2.0-9.3) mm. Successful transcatheter closure was achieved in 11 cases. The mean weight at 1-month follow-up after defect closure was 13.5 kg (6.2-19.8 kg; mean Z-score: -0.2). The mean length of hospitalization was 2.7 days.

Conclusions: This study highlights the potential safety and therapeutic efficacy of transcatheter ventricular septal defect closure in infants with low weight. Considerable weight gain and heart failure symptom attenuation at 1 month after transcatheter closure were observed.

Citing Articles

Safety, effectiveness, and complications of the first-in-human minimally invasive transthoracic ventricular septal defect closure using a bioabsorbable occluder: a cohort study with 12-month follow-up.

Zhang Q, Zhou J, Zhu S, Liu H, Mao Y, Tang Y Cardiovasc Diagn Ther. 2024; 14(4):630-641.

PMID: 39263475 PMC: 11384464. DOI: 10.21037/cdt-23-361.


Transthoracic device closure of perimembranous ventricular septal defect via a small left intercostal incision in children.

Xie L, Zhang G, He J, Shen Y, Liao D, Chen L Front Cardiovasc Med. 2023; 10:1221136.

PMID: 37671138 PMC: 10476519. DOI: 10.3389/fcvm.2023.1221136.

References
1.
Anderson B, Stevens K, Nicolson S, Gruber S, Spray T, Wernovsky G . Contemporary outcomes of surgical ventricular septal defect closure. J Thorac Cardiovasc Surg. 2013; 145(3):641-7. DOI: 10.1016/j.jtcvs.2012.11.032. View

2.
Bian C, Ma J, Wang J, Xu G, Jiang J, Yao S . Perimembranous ventricular septal defect with aneurysm: two options for transcatheter closure. Tex Heart Inst J. 2011; 38(5):528-32. PMC: 3231530. View

3.
Pamukcu O, Narin N, Baykan A, Sunkak S, Tasci O, Uzum K . Mid-term results of percutaneous ventricular septal defect closure with Amplatzer Duct Occluder-II in children. Cardiol Young. 2017; 27(9):1726-1731. DOI: 10.1017/S104795111700107X. View

4.
Pillai A, Rangasamy S, Balasubramonian V . Transcatheter Closure of Moderate to Large Perimembranous Ventricular Septal Defects in Children Weighing 10 kilograms or less. World J Pediatr Congenit Heart Surg. 2019; 10(3):278-285. DOI: 10.1177/2150135119825562. View

5.
Bilen C, Akkaya G, Tuncer O, Atay Y . Assessment of Tricuspid Valve Detachment Efficiency for Ventricular Septal Defect Closure: A Retrospective Comparative Study. Acta Cardiol Sin. 2020; 36(4):360-366. PMC: 7355110. DOI: 10.6515/ACS.202007_36(4).20191012A. View